J. Leempoels

532 total citations
18 papers, 432 citations indexed

About

J. Leempoels is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, J. Leempoels has authored 18 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in J. Leempoels's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Blood Pressure and Hypertension Studies (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). J. Leempoels is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Blood Pressure and Hypertension Studies (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). J. Leempoels collaborates with scholars based in Belgium, United States and Switzerland. J. Leempoels's co-authors include H. Verhaegen, J. De Crée, W. De Cock, W. Meuldermans, Jan Hendrickx, Nancy Van Osselaer, Tom Verhaeghe, L. Le Jeune, Ludy van Beijsterveldt and A. Van Peer and has published in prestigious journals such as The Lancet, Neurology and Journal of Hepatology.

In The Last Decade

J. Leempoels

18 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Leempoels Belgium 11 119 116 106 88 68 18 432
F. Pommier Switzerland 18 92 0.8× 295 2.5× 83 0.8× 45 0.5× 36 0.5× 37 762
Mitsugu Hachisu Japan 14 164 1.4× 113 1.0× 109 1.0× 35 0.4× 73 1.1× 59 523
Rodolfo Testa Italy 15 280 2.4× 61 0.5× 117 1.1× 64 0.7× 74 1.1× 34 617
Shiro Shirakura Japan 10 97 0.8× 47 0.4× 71 0.7× 63 0.7× 91 1.3× 25 339
G Sędek Switzerland 15 51 0.4× 213 1.8× 85 0.8× 30 0.3× 59 0.9× 26 659
Margaret Binnie United Kingdom 15 242 2.0× 116 1.0× 77 0.7× 161 1.8× 20 0.3× 23 848
Gareth Maher‐Edwards United Kingdom 8 116 1.0× 147 1.3× 95 0.9× 41 0.5× 17 0.3× 16 390
Sonia Gallego‐Sandín Spain 13 227 1.9× 173 1.5× 104 1.0× 23 0.3× 63 0.9× 17 632
Randy Dockens United States 13 168 1.4× 167 1.4× 165 1.6× 58 0.7× 19 0.3× 36 751
J. Harting Germany 14 206 1.7× 58 0.5× 109 1.0× 54 0.6× 85 1.3× 23 540

Countries citing papers authored by J. Leempoels

Since Specialization
Citations

This map shows the geographic impact of J. Leempoels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Leempoels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Leempoels more than expected).

Fields of papers citing papers by J. Leempoels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Leempoels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Leempoels. The network helps show where J. Leempoels may publish in the future.

Co-authorship network of co-authors of J. Leempoels

This figure shows the co-authorship network connecting the top 25 collaborators of J. Leempoels. A scholar is included among the top collaborators of J. Leempoels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Leempoels. J. Leempoels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
McLeod, James F., et al.. (2014). GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. British Journal of Anaesthesia. 113(5). 875–883. 27 indexed citations
2.
Bourgeois, Stefan, H.W. Reesink, J. Leempoels, et al.. (2013). 1188 COMBINATION THERAPY OF TMC647055 WITH SIMEPREVIR (TMC435) IN CHRONIC HEPATITIS C PATIENTS. Journal of Hepatology. 58. S483–S483. 6 indexed citations
3.
Tseng, Jack, Marissa F. Dockendorf, Gopal Krishna, et al.. (2012). P1‐221: Safety and pharmacokinetics of the novel BACE inhibitor MK‐8931 in healthy subjects following single‐ and Multiple‐Dose administration. Alzheimer s & Dementia. 8(4S_Part_5). 3 indexed citations
4.
Forman, Mark S., John Palcza, Jack Tseng, et al.. (2012). P4‐196: The novel BACE inhibitor MK‐8931 dramatically lowers cerebrospinal fluid Aβ peptides in healthy subjects following single‐ and multiple‐dose administration. Alzheimer s & Dementia. 8(4S_Part_19). 38 indexed citations
5.
Forman, Mervyn B., Jeng‐Sen Tseng, John Palcza, et al.. (2012). The Novel BACE Inhibitor MK-8931 Dramatically Lowers CSF A  Peptides in Healthy Subjects: Results from a Rising Single Dose Study (PL02.004). Neurology. 78(Meeting Abstracts 1). PL02.004–PL02.004. 13 indexed citations
6.
Cleton, Adriaan, Krishna Talluri, J. Leempoels, et al.. (2009). No pharmacokinetic interaction between paliperidone extended‐release tablets and trimethoprim in healthy subjects. Human Psychopharmacology Clinical and Experimental. 24(7). 532–539. 26 indexed citations
7.
Cleton, Adriaan, Adriaan Cleton, Krishna Talluri, et al.. (2006). PI-58No pharmacokinetic interaction between trimethoprim and paliperidone ER in healthy subjects. Clinical Pharmacology & Therapeutics. 79(2). P22–P22. 9 indexed citations
8.
Mannens, Geert, Jan Hendrickx, Tom Verhaeghe, et al.. (2002). The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans. Drug Metabolism and Disposition. 30(5). 553–563. 81 indexed citations
9.
10.
11.
Leempoels, J., et al.. (1985). Comparison of Blood Pressure Ratio by Doppler Velocimetry and by Plethysmography During Treatment with Ketanserin, a 5-HT2 Receptor Antagonist. Journal of Cardiovascular Pharmacology. 7. 92–94. 8 indexed citations
12.
Leempoels, J., et al.. (1985). The effects of ketanserin, a 5-HT 2 receptor antagonist on the impaired blood cell filtration in patients with acute myocardial infarction. Clinical Hemorheology and Microcirculation. 5(6). 949–957. 4 indexed citations
13.
Crée, J. De, et al.. (1985). Ketanserin and Red Blood Cell Sodium Content in Hypertension. Journal of Cardiovascular Pharmacology. 7. 41–43. 13 indexed citations
14.
Crée, J. De, et al.. (1985). Effect of Ketanserin on the Hyperreactivity of Platelets to 5-Hydroxytryptamine in Patients with Cardiovascular Diseases. Journal of Cardiovascular Pharmacology. 7. 26–28. 10 indexed citations
15.
Leempoels, J., et al.. (1984). PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION. The Lancet. 324(8406). 775–779. 36 indexed citations
16.
Raeman, F., et al.. (1982). Enumeration of T-lymphocytes and T-lymphocyte subsets in rheumatoid arthritis using monoclonal antibodies. Clinical Rheumatology. 1(3). 194–198. 3 indexed citations
17.
Leempoels, J., et al.. (1981). The Antihypertensive Effects of Ketanserin (R 41 468), a Novel 5-Hydroxytryptamine-Blocking Agent, in Patients with Essential Hypertension. Clinical Science. 61(s7). 473s–476s. 26 indexed citations
18.
Crée, J. De, et al.. (1981). The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients. Angiology. 32(2). 137–144. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Pommier Breakdown of academic impact, for papers by Mitsugu Hachisu Breakdown of academic impact, for papers by Rodolfo Testa Breakdown of academic impact, for papers by Shiro Shirakura Breakdown of academic impact, for papers by G Sędek Breakdown of academic impact, for papers by Margaret Binnie Breakdown of academic impact, for papers by Gareth Maher‐Edwards Breakdown of academic impact, for papers by Sonia Gallego‐Sandín Breakdown of academic impact, for papers by Randy Dockens Breakdown of academic impact, for papers by J. Harting
Rankless by CCL
2026